Similar Articles
821 Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
822 How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
823 Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
824 Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression
825 Understanding the role of PIN1 in hepatocellular carcinoma
826 Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
827 Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
828 Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation
829 Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
830 Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA